Condition: Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused · Sponsor: Jose Cancelas
This research is being done to compare the red blood circulation survival in healthy adult volunteers between the 51 chromium (51Cr) red blood cell (RBC) labeling method and the Biotin (BioRBC) red blood cell (RBC) labeling method to determine if biotinylated red blood cells (BioRBC) is an acceptable non radioactive alternative to 51 chromium (51Cr) radiolabeling for regulatory pharmacokinetic studies of red blood cell products.
This description comes directly from the study's public registry record.
Jose A Cancelas-Perez, MD, PhD · 617-632-3446 · jose_cancelas-perez@dfci.harvard.edu
Always discuss trial participation with your own doctor first.
| Hoxworth Blood Center, University of Cincinnati | Cincinnati, Ohio, United States | Recruiting |
| American Red Cross | Norfolk, Virginia, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07446647